Epidemiology, aetiology and screening of bladder cancer
| Autor: | Marcus G. Cumberbatch, Aidan P. Noon |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Epidemiology aetiology Urology Review Article Disease Tobacco smoke 03 medical and health sciences 0302 clinical medicine Environmental health Health care medicine cancer Risk factor bladder Bladder cancer business.industry screening Incidence (epidemiology) Cancer medicine.disease 030104 developmental biology Reproductive Medicine 030220 oncology & carcinogenesis business |
| Zdroj: | Translational Andrology and Urology |
| ISSN: | 2223-4691 2223-4683 |
| DOI: | 10.21037/tau.2018.09.11 |
| Popis: | Bladder cancer (BC) is a common, significant and expensive health condition. Understanding the risk factors for this disease is paramount to improving disease prevention and increasing public awareness. Historically BC has been a disease of industrialized regions and the most responsible carcinogens are tobacco smoke and occupational chemical exposure. BC incidence and mortality differ dramatically by region and reflect differences in risk factor exposure, healthcare behaviour, and population demographics. Screening studies have suggested a survival benefit amongst screened non-symptomatic populations with known risk factors, but this has not become standard practice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|